FAM134B is the earliest identified and most studied ER-phagy receptor in mammals, mediating autophagic degradation of ER [17, 19, 47], and its changes in expression or oligomerization are closely associated with tumorigenesis, viral infections, and neurological diseases [46, 50, 51]. This evidence concerns the gene RETREG1 and viral infectious disease.